This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Steris Healthcare, a pharmaceuticalcompany headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627.
In October 2024, the programme entered a strategic commercial partnership with Sun Pharma, a leading multinational pharmaceuticalcompany. The study is expected to complete enrollment between Q4 2025 and Q1 2026. The soft tissue sarcoma trials are progressing as planned across Europe and the United States. In the U.S.,
Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season. 3 References 1. June 9, 2025.
Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceuticalcompany ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.
The initiative comes at a crucial time, as British pharmaceuticalcompanies are significantly increasing their investments in the United States. Outlaid via the Life Sciences Innovative Manufacturing Fund (LSMIF), the investment will aim to expand the UK’s manufacturing capabilities and supply chain security.
The company expects the two moves together will result in more than $400 million in annual cost savings in 2026. But the steady expansion of their use has slowed and, despite much trying, pharmaceuticalcompanies have largely failed to top the drugs’ successes. By Jonathan Gardner • Sept.
This is an opportunity for pharmaceuticalcompanies to support patients via a hub-and-spoke model where the trial might be conducted in Houston but some of the patients live in South Texas.
Image credit: PeopleImages.com – Yuri A via Shutterstock With tighter budgets, regulatory challenges, and uncertainty from tariffs, pharmaceuticalcompanies are turning to third-party logistics (3PL) suppliers to deliver efficiencies. That is very challenging to manage all these complexities.
While most use cases remain theoretical, early-stage collaborations between quantum computing companies and pharmaceuticalcompanies are exploring how quantum platforms might enhance protein modelling, molecular docking and energy-state simulations.
WASHINGTON — The Biden administration is making its opening offers to pharmaceuticalcompanies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. The negotiated prices won’t take effect until 2026. And that’s about all they said.
Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceuticalcompanies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months.
German drugmaker Boehringer Ingelheim is the latest pharmaceuticalcompany to sue the federal government over a law that would allow Medicare to negotiate certain drug prices, Reuters reports. Continue to STAT+ to read the full story…
Steris Healthcare, a pharmaceuticalcompany headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627.
Once completed, the 40,000-square-metre centre will be used to produce active pharmaceutical ingredients (API) for biosimilars in Sandoz’s rheumatology, oncology and immunology portfolio. Sandoz is the parent company of Lek Pharmaceuticals , the oldest pharmaceuticalcompany in Slovenia.
Radioligand therapies (RLTs) have received prominent attention from major pharmaceuticalcompanies in treating prostate cancer. Bayer’s Xofigo (radium-223 dichloride) demonstrated the proof-of-concept with its FDA approval for castration-resistant prostate cancer (CRPC).
India-based pharmaceuticalcompany Cipla has entered into a perpetual licence agreement with Swiss drugmaker Novartis Pharma for the diabetes drug Galvus and its combination brands. Under the deal, Cipla will be responsible for the manufacturing and marketing of Galvus and its combination brands from 1 January 2026.
The global pharmaceutical industry experienced a 17% rise in company filings mentions of blockchain in Q1 2023 compared with the previous quarter, with the highest share accounted for by Bayer, according to GlobalData’s analysis of over 60 pharmaceuticalcompany filings.
US-based pharmaceuticalcompanies Enliven Therapeutics and Imara have entered a definitive merger deal in an all-stock transaction to advance oncology product candidates. Once the merger has closed, a clinical-stage biopharmaceutical company will be created that will operate under the name Enliven Therapeutics.
This is a golden opportunity for pharmaceuticalcompanies to deploy the power of data and digital to laser-focus delivery across its client base, ultimately improving the value of engagements and capturing market share, says Treasure Data founder and CEO Kazuki Ohta. Capturing market share. billion in 2021 to $9.23
In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceuticalcompanies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. By 2026, the report predicts that each of the top 10 selling orphan drugs will earn between $3 billion and $13 billion.
The building – which will be designed by Kadans – is expected to be open for business in 2026, and according to a Financial Times report is expected to cost around £500 million ($657 million) to construct. ” The project has been announced after the UK life sciences sector enjoyed a record year for investment, raising £4.5
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.
The company undertook several initiatives recently to expand its business through new partnerships, expansion of existing relationships, and investment in manufacturing capacity. Key among them has been the extension of Syngene’s research collaboration with leading biotech company Amgen Inc. until 2026.
There are multiple drugs in the pipeline, predominantly me-too and biosimilar therapies, with a significant number developed in the emerging markets of India and China by domestic pharmaceuticalcompanies for their own rapidly growing markets.
… Pharmaceuticalcompanies are due to receive by Thursday the U.S. Five Wall Street analysts and two investors told Reuters they expect the negotiations over prices that will go into effect in 2026 to result in cuts ranging from the statutory minimum of 25% to as much as 60% when the final numbers are set in September.
A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drug makers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.
… The Biden administration is making its opening offers to pharmaceuticalcompanies in its brand-new Medicare drug price negotiation program on Thursday, but declined to disclose any details , STAT tells us. Companies have until March 2 to either accept the government’s offer or propose a counteroffer.
… Four pharmaceuticalcompanies involved in the negotiations over prices for Medicare do not expect a significant impact on their businesses after seeing confidential suggested prices from the government for their drugs that will take effect in 2026 , Reuters writes.
. – Considering that the government promotes companies to “Make in India”, we request that the time limit for commencing manufacturing or production be further extended to 31 March 2026. Expectation #4 Clarification on product samples and low brand value items – According to CBDT circular no. 18 of 2022 (Question No.
With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market. With the expanding acceptance among HCPs, patients, and researchers, radiopharmaceutical companies are estimated to touch the $7.5B threshold by 2026.
Faster is just one of the areas of focus for NICE as set out in their five year strategy , running from 2021 to 2026. Ensuring wider use of new medicines is what will make the UK market really attractive to pharmaceuticalcompanies. months on average from marketing authorisation to final NICE output in 2020/21.
COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. appeared first on.
Waite further emphasizes the need for pharmaceuticalcompanies to quickly build internal capabilities in customs compliance, including tariff classification, country of origin documentation, and accurate customs valuation. Related Content Advertisement July 24th 2025 Opposing Reactions as RFK Jr.
IQVIA Institute models global cumulative spend on COVID-19 vaccines to be a base case of $251bn to 2026 , with spend on COVID-19 treatments, including the new oral agents and treatments of post-viral syndromes, likely to add significant incremental spend. Medicine budget constraint, structural fund largesse.
By the end of 2026, the company will be able to analyze two million genomes. Life sciences companies can adopt third-party software-as-a-service (SaaS) solutions for drug discovery or build custom tools in collaboration with a cloud provider.
as early as the 2026-2027 flu season. But the steady expansion of their use has slowed and, despite much trying, pharmaceuticalcompanies have largely failed to top the drugs’ successes. By Jonathan Gardner • Sept. 4, 2024 Adeline Kon/BioPharma Dive Deep Dive // Emerging biotech Biotech IPOs are the industry’s lifeblood.
At a July 8th cabinet meeting, the president said that pharmaceuticals would be tariffed at a quote very high rate, like 200%. And and he also indicated that we plan to start with a low tariff to give pharmaceuticalcompanies time to build. More recently, he said the tariffs would take effect as soon as the end of this month.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content